Status and strategies for the management of head and neck cancer during COVID-19 pandemic: Indian scenario.


Journal

Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 21 04 2020
accepted: 24 04 2020
pubmed: 2 5 2020
medline: 23 7 2020
entrez: 2 5 2020
Statut: ppublish

Résumé

In India, oral cancer is the most common head and neck cancer (HNC) in men, mainly caused by the consumption of smoked and smokeless tobacco. During the current pandemic, delaying surgery for even 1 or 2 months may lead to more extensive surgery or inoperability, where only supportive care can be provided. Being semi-emergent in nature, treatment for these patients is currently on hold or delayed in most centers across the country. This study was conducted to assess the impact of COVID-19 pandemic and inability of the health system to treat HNC in a timely fashion and how surgeons are coping to this emergent situation. This article highlights the situation in India, a country burdened with one of the highest incidence rates of HNC.

Identifiants

pubmed: 32357281
doi: 10.1002/hed.26227
pmc: PMC7267542
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1460-1465

Informations de copyright

© 2020 Wiley Periodicals, Inc.

Références

Epidemiol Health. 2017 Mar 9;39:e2017009
pubmed: 28292008
Oral Oncol. 2017 Apr;67:1-9
pubmed: 28351561
Head Neck. 2020 Jul;42(7):1460-1465
pubmed: 32357281
JAMA. 2020 Feb 28;:
pubmed: 32108857
J Cancer Epidemiol. 2012;2012:701932
pubmed: 23093961

Auteurs

Anand Gupta (A)

Department of Dentistry (Oral and Maxillofacial Surgery), Government Medical College & Hospital, Chandigarh, India.

Vipin Arora (V)

Department of ENT and Head Neck Surgery, University College of Medical Sciences and GTB Hospital, Delhi, India.

Deepa Nair (D)

Department Head and Neck Surgical Oncology, Tata Memorial Centre, HBNI University, Mumbai, India.

Nishant Agrawal (N)

Section of Otolaryngology-Head and Neck Surgery, Department of Surgery, University of Chicago, Chicago, Illinois, USA.

Yu-Xiong Su (YX)

Division of Oral and Maxillofacial Surgery, Faculty of Dentistry, The University of Hong Kong, Hong Kong SAR.

F Christopher Holsinger (FC)

Division of Head and Neck Surgery, Stanford University, Palo Alto, California, USA.

Jason Y K Chan (JYK)

Department of Otorhinolaryngology, Head and Neck Surgery, The Chinese University of Hong Kong, Hong Kong SAR.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH